{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:47:48Z","timestamp":1777664868559,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,17]]},"DOI":"10.7759\/cureus.86236","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T21:08:02Z","timestamp":1750194482000},"source":"Crossref","is-referenced-by-count":1,"title":["Rare Presentation of Metastatic Breast Cancer Involving the Peritoneal Cavity: Two Cases Arising From Stage 0\/1 Disease"],"prefix":"10.7759","author":[{"given":"Emily","family":"Saurborn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessia","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waqas","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan M","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista L","family":"Denning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Legenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Krutzler-Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Ductal carcinoma in situ (DCIS). (2021). Accessed. September 6, 2024: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/about\/types-of-breast-cancer\/dcis.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.20.1546","article-title":"Detection of ductal carcinoma in situ in women undergoing screening mammography","volume":"94","author":"Ernster VL","year":"2002","unstructured":"Ernster VL, Ballard-Barbash R, Barlow WE, et al.. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002, 94:1546-54. 10.1093\/jnci\/94.20.1546","journal-title":"J Natl Cancer Inst"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01779-3","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance","volume":"9","author":"Wang J","year":"2024","unstructured":"Wang J, Li B, Luo M, et al.. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance. Signal Transduct Target Ther. 2024, 9:83. 10.1038\/s41392-024-01779-3","journal-title":"Signal Transduct Target Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.8.2263","article-title":"Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853","volume":"19","author":"Bijker N","year":"2001","unstructured":"Bijker N, Peterse JL, Duchateau L, et al.. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol. 2001, 19:2263-71. 10.1200\/JCO.2001.19.8.2263","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00376-9","article-title":"Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer","volume":"8","author":"Sparano JA","year":"2022","unstructured":"Sparano JA, O'Neill A, Graham N, et al.. Inflammatory cytokines and distant recurrence in HER2-negative early breast cancer. NPJ Breast Cancer. 2022, 8:16. 10.1038\/s41523-021-00376-9","journal-title":"NPJ Breast Cancer"},{"key":"ref6","article-title":"Breast cancer","author":"Menon G","year":"2024","unstructured":"Menon G, Alkabban FM, Ferguson T. Breast cancer. Menon G, Alkabban FM, Ferguson T (ed): StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-022-01030-w.","article-title":"Does the status of the tumor bed at surgical margins affect local recurrence and overall prognosis in patients undergoing lumpectomy status post neoadjuvant therapy? (abs # 203)","volume":"35","author":"Zhao X","year":"2022","unstructured":"Zhao X, Nayak A, Bleiweiss IJ. Does the status of the tumor bed at surgical margins affect local recurrence and overall prognosis in patients undergoing lumpectomy status post neoadjuvant therapy? (abs # 203). Mod Pathol. 2022, 35:222-225. 10.1038\/s41379-022-01030-w.","journal-title":"Mod Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57010062","article-title":"Triple negative breast cancer: a review of present and future diagnostic modalities","volume":"57","author":"Dass SA","year":"2021","unstructured":"Dass SA, Tan KL, Selva Rajan R, et al.. Triple negative breast cancer: a review of present and future diagnostic modalities. Medicina (Kaunas). 2021, 57:10.3390\/medicina57010062","journal-title":"Medicina (Kaunas)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04772-6","article-title":"Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC)","volume":"479","author":"Mustafa M","year":"2024","unstructured":"Mustafa M, Abbas K, Alam M, et al.. Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC). Mol Cell Biochem. 2024, 479:895-913. 10.1007\/s11010-023-04772-6","journal-title":"Mol Cell Biochem"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Gradishar WJ","year":"2022","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al.. Breast cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022, 20:691-722. 10.6004\/jnccn.2022.0030","journal-title":"J Natl Compr Canc Netw"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024, 74:12-49. 10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-90003-20","article-title":"Extending survival with chemotherapy in metastatic breast cancer","volume":"10 Suppl 3","author":"O'Shaughnessy J","year":"2005","unstructured":"O'Shaughnessy J. Extending survival with chemotherapy in metastatic breast cancer. Oncologist. 2005, 10 Suppl 3:20-9. 10.1634\/theoncologist.10-90003-20","journal-title":"Oncologist"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-017-0753-4","article-title":"Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer","volume":"24","author":"Inoue M","year":"2017","unstructured":"Inoue M, Nakagomi H, Nakada H, et al.. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer. Breast Cancer. 2017, 24:667-72. 10.1007\/s12282-017-0753-4","journal-title":"Breast Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.14032","article-title":"Diffuse peritoneal carcinomatosis with ascites and disseminated bone marrow carcinomatosis as initial presentation of occult breast cancer","volume":"26","author":"Patwari A","year":"2020","unstructured":"Patwari A, Bhatlapenumarthi V. Diffuse peritoneal carcinomatosis with ascites and disseminated bone marrow carcinomatosis as initial presentation of occult breast cancer. Breast J. 2020, 26:2233-4. 10.1111\/tbj.14032","journal-title":"Breast J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen M","year":"2014","unstructured":"Miettinen M, McCue PA, Sarlomo-Rikala M, et al.. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2014, 38:13-22. 10.1097\/PAS.0b013e3182a0218f","journal-title":"Am J Surg Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000531835","article-title":"Large ascites in a cirrhotic patient reveal an isolated and late metastasis of ductal breast cancer: a case study","volume":"16","author":"Mostafa S","year":"2023","unstructured":"Mostafa S, Habib MB, Ahmed N, Sawaf B, Sadik N, Abdulhadi AM. Large ascites in a cirrhotic patient reveal an isolated and late metastasis of ductal breast cancer: a case study. Case Rep Oncol. 2023, 16:585-90. 10.1159\/000531835","journal-title":"Case Rep Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_49_17","article-title":"Liver metastasis in a young female secondary to breast cancer: a case report","volume":"7","author":"Al Qahtani SY","year":"2019","unstructured":"Al Qahtani SY, Al Argan RJ. Liver metastasis in a young female secondary to breast cancer: a case report. Saudi J Med Med Sci. 2019, 7:190-4. 10.4103\/sjmms.sjmms_49_17","journal-title":"Saudi J Med Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5367","article-title":"Peritoneal metastases from breast cancer: a scoping review","volume":"11","author":"Beniey M","year":"2019","unstructured":"Beniey M. Peritoneal metastases from breast cancer: a scoping review. Cureus. 2019, 11:e5367. 10.7759\/cureus.5367","journal-title":"Cureus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.11473","article-title":"Response to first-line recurrence treatment influences survival in hormone receptor-positive, HER2-negative breast cancer: a multicenter study","volume":"33","author":"Yamamura J","year":"2019","unstructured":"Yamamura J, Kamigaki S, Tsujie M, et al.. Response to first-line recurrence treatment influences survival in hormone receptor-positive, HER2-negative breast cancer: a multicenter study. In Vivo. 2019, 33:281-7. 10.21873\/invivo.11473","journal-title":"In Vivo"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-018-9416-0","article-title":"The emerging roles of steroid hormone receptors in ductal carcinoma in situ (DCIS) of the breast","volume":"23","author":"Villanueva H","year":"2018","unstructured":"Villanueva H, Grimm S, Dhamne S, et al.. The emerging roles of steroid hormone receptors in ductal carcinoma in situ (DCIS) of the breast. J Mammary Gland Biol Neoplasia. 2018, 23:237-48. 10.1007\/s10911-018-9416-0","journal-title":"J Mammary Gland Biol Neoplasia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/323287-rare-presentation-of-metastatic-breast-cancer-involving-the-peritoneal-cavity-two-cases-arising-from-stage-01-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T21:08:04Z","timestamp":1750194484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/323287-rare-presentation-of-metastatic-breast-cancer-involving-the-peritoneal-cavity-two-cases-arising-from-stage-01-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.86236","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}